Elimination of waste in patients with MS: what can be done for ease their discomfort? by unknown
  
 
Kandidat nr. 2011 
 
 
Elimination of waste in patients with MS: what can be done to ease 
their discomfort? 
 
 
 
 
 
 
 
Bachelor oppgave i sykepleie 2012 
 
Diakonhjemmet Høyskole, avdeling for sykepleieutdanning 
 
Kull 09FUS 
 
Antall ord: 9580 
 
 
 
 
 
 
 
 
 
2 
 
 
 
Abstract 
 
Multiple Sclerosis (MS) is the most common neurological disease affecting young people in 
the western world. Bladder and bowel dysfunction are reported to be among the most 
common and distressing of symptoms and yet haven’t been thoroughly researched. This thesis 
looks at the symptoms affecting the bladder and bowel and the management of them. It also 
shows how nurses can have an important role to play in reducing the effects of these 
symptoms and how they are intimately involved in helping patients manage these frustrating 
problems.     
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1.0 Introduction 
 
 
1.1 Background  
Part of the reason for choosing this arena for my thesis is the interest I have had in MS since I 
was a child. In primary school we would have an MS-read-a-thon every year to raise money 
for research of the disease and I could never quite get out of my head the image of the lady in 
the film trying to pick up a glass of water but missing it. 
 
Since then I have worked with MS patients in their homes while I was living in London, and 
in nursing homes here in Norway. My most recent experience was with a 60 year old man 
who, after 20 years of suffering from MS, died from complications that started with bowel 
problems and then dominoed into a sequence of symptoms that ultimately led to pulmonary 
asphyxiation. This tragedy convinced me to look more specifically into MS and the problems 
that can arise...specifically the difficulties with the bowels and bladder. From a nursing 
perspective I wondered what could have been done to a) prevent this from happening and b) 
what treatments were available to the patient before his situation became so extreme. 
 
 
1.2 Problem 
 
Many of the articles I have read in my research have mentioned how bowel problems haven’t 
been researched thoroughly. Norton (2010) goes so far as to say that “…no more recent work 
on the impact of bowel function or coping methods could be found” since she quotes Bauer et 
al, from 1965. This surprised me. This discovery almost made me concentrate on just the 
bowel problems MS patients have.  
 
The problem with the bladder and bowels is usually coupled with sexual dysfunction 
particularly since they deal with the intimate parts of the body, the privacy issue (DasGupta 
and Fowler 2003). But given the limitations, both word and time wise, I have chosen to stay 
with the elements of elimination. 
 
Nurses have an important role to play in this particular problem. Woodward writes about the 
important role MS nurses can play in assisting patients with these problems. Not only 
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physically with, for example, patients with an advanced disease living in institutions but also 
as someone who can provide advice and training with the different aspects of the problem. 
“Nurses can have a significant role to play in reducing bladder symptoms and directly 
improving patients’ quality of life” (Woodward 2004). 
 
The problem, the challenge then is: 
 
Elimination of waste in patients with MS: what can be done to ease their discomfort?  
 
I have chosen to use the wording “ease their discomfort” because these words reflect both the 
physical and psychological elements that elimination problems can cause. I have also chosen 
to omit the word “advanced MS” since treatment depends on symptoms and each individual 
patient as opposed to the degree of the disease (even though the level of disability often 
affects the level of bowel and bladder dysfunction). 
 
 
1.3 Limitations 
 
Multiple Sclerosis is a disease with a long list of symptoms from fatigue to spasms, pain to 
visual disturbances and as McDonnell (2007) says “It may be observed that no two cases of 
any disease are alike, but this is particularly so for multiple sclerosis” (2007). Looking into 
MS as an entirety would not only require a lot more time for research but a lot more than 10 
000 words to explain. It is a complex, chronic neurological disorder that even neurologists 
don't completely understand. There is no cure and no real understanding of where the disease 
comes from. It is a disease where a patient is predominantly treated symptomatically and in 
this case I have chosen to look at an aspect of the disease that many other researches claim 
has been neglected: Elimination. 
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1.4 Definitions 
 
Antichololinergies= inhibitors for nerve impulses 
CNS= Central Nervous System the brain, the spine…. 
Demyelation= where the myelin sheath protecting nerve fibers is damaged 
Hyperreflexia= overactive or over responsive reflexes 
Hyporeflexia= below normal or absent reflexes 
Intravesical= treatment that is put directly into the bladder rather than orally or injected 
MS = Multiple Sclerosis 
Plaque/Lesion= scarring of myelin  
Suprapubic catheter= inserted through your abdomen directly into the bladder 
Voiding= urinating 
 
 
1.5 Preface 
 
Due to my work with MS patients I have over the years gained knowledge of the disease from 
patients, books and my own experiences. In the beginning I had mostly read brochures from 
the different MS Societies and the limited text books in libraries but in the last ten years the 
internet has become a rich source of information. I understood how demyelation could affect 
mobility, muscles and the extremities but not the other neurological implications and 
symptoms. My nursing education has had a significant impact on my general knowledge of 
how the body works and thus how MS affects the anatomy but the detailed research and close 
examination of medical articles required for this thesis has managed to give me a number of 
“Aha experiences” that have influenced the way I see MS. 
 
My nine weeks practical experience in Drammen Hospital's gastro-intestinal surgical ward 
opened my eyes to the complexity of and yet simplicity of the way our digestive system 
works. It works like a charm despite the junk we put into ourselves and the irregular eating 
habits we have. It's a matter of fact, we take it for granted and only when something goes 
wrong do we see its importance. 
 
What I wanted to do with this thesis was look at the way nurses can influence the lives but 
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more particularly the symptoms MS patients suffer. The bowels and bladder are an important 
part of our bodily system but more specifically they are an intimate part of our anatomy. They 
produce waste that we do not put on display for others. If accidents occur they are 
embarrassing, they smell and make a mess. This is not something a patient can talk to just 
anyone about...often, even ones partner is excluded. I think nurses can be a great source of 
help in this particular area. A nurse with the right knowledge of both the disease and the 
measures that can help could be a great comfort to MS sufferers. 
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2.0 Method 
 
Dalland defines method as a procedure, a means to solve problems and arrive at new 
knowledge. Anything that serves this purpose is part of the arsenal of methods (Aubert 1985, 
cited in Dalland 2007:81). This thesis will be a literature study of research articles.  
 
 
2.1 Literary Study 
 
A literature study is a qualitative method. It is a method that increasingly aims to capture the 
meaning and experience in a particular field (Dalland 2007:82). Other types of qualitative 
methods include interview or observation. That which characterises the use of qualitative 
methods is the level of depth one goes into the specific thing we want to find.  An example 
where one uses qualitative methods in nursing is sitting down to talk with and observe the 
patient directly (ibid. 2007:85). 
 
I collected the research literature from other studies as a basis of responding to the problem I 
am presenting in this thesis. The purpose of a literature search is to accumulate knowledge on 
a subject that has already been researched and written about (ibid. 2007: 106).   
 
 
2.2 Search process and collection of information 
 
I chose to use CINAHL and Google Academic as my search engines. In CINAHL I specified 
full-text, peer reviewed articles from 2006 onwards. I discovered that of the articles I found, 
many authors referenced articles further back to experts such as DasGupta and Fowler. I felt 
these were important to include so I expanded my search to include the last 10 years, from 
2002 to 2012, with most articles published after 2005. 
 
Not all the articles I wanted were in full text. The ones of most significance and relevance 
needed to be ordered from the university library. In these cases I found that the abstracts 
presented in the search were vital sources for selecting the right research for my thesis. The 
detailed abstracts were invaluable in saving both time and effort. 
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I entered the words Multiple Sclerosis AND Bowel dysfunction as well as Multiple Sclerosis 
AND Bladder dysfunction. I received an equal number of hits on both; 15. However, most of 
these articles covered both the bladder and bowel. 
 
My search in Google Academic was more of a backup search to CINAHL, mostly to see if 
there were ways to get to open articles in full text. But the point behind this became redundant 
when I was able to receive the research I wanted from the library. 
 
 
2.3 Presentation of articles 
 
I have a collection of 13 articles that I have used in my research. I started off with 16 but have 
cut 3 on the basis that they mainly discuss prevalence and are not helpful in answering the 
problem I have put forward with this thesis. All but one of the articles I have chosen are peer 
reviewed pieces published in a range of journals or collection of seminars. One article by 
MacLean (2010) is not related solely to either bladder or bowel problems but discusses MS 
and its symptoms as a whole. I have chosen to include this article because it focused 
particularly on the nurse’s role in promoting symptomatic management to improve the quality 
of life for MS patients.  
 
The World Federation of Neurology (WFN) published a collection of seminars focusing on 
the neurologic bladder, bowel and sexual dysfunction. I have included chapter five by 
Frohman which specifically targeted MS. The WFN has also published a collection of 
seminars discussing MS where chapter two by Brady and Fowler focused on urinary 
incontinence and retention and chapter three by Brady took a look at constipation and fecal 
incontinence. 
 
An article by Adelson (2011) published in the MS Society magazine Momentum in the USA is 
not peer reviewed but is written in such a way that makes it very accessible to the ordinary 
person. It is a very quotable article and even though Adelson is no MS expert she interviews 
an expert and gets her information from there. 
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The rest of the articles are written by experts in their fields. Both neurologists, nurses working 
in neurology or in incontinence and research referencing many of the authors I have used 
here. I found the references at the back of all these articles very useful in my own search for 
references. 
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3.0 Theory 
 
 
3.1 Introduction 
 
Multiple Sclerosis (MS) is the disease of the central nervous system (CNS) that most 
frequently leads to disability in young adults in the western world and if affects more than 
twice as many women as it does men (WHO 2008). It debuts most often between the ages of 
20-40 but has been known to strike at all ages (Ørn 2011). It is estimated that 75% of all 
patients with MS develop bladder dysfunction (DasGupta 2003) while between 29-43% are 
affected by constipation and 50% with faecal incontinence (Norton 2010). Urinary 
dysfunction has been looked at extensively in the past and there is much that can be done to 
alleviate the symptoms relating to this particular problem. But when it come to the bowels and 
sexual dysfunction very little research has been done despite the fact that these are among the 
problems that are most distressing for patients (Das Gupta 2003). 
 
Partly because of the lack of research and partly because of the private nature of the problem, 
it is important for professional nurses to be up to date with their evidence based knowledge of 
the disease in order to provide quality care for patients. As MacLean (2010) further puts it 
“…the team of healthcare professionals, can enable the individual to come to terms with the 
diagnosis and cope better with future uncertainty”. 
 
 
3.1.1 Pathophysiology 
 
Multiple Sclerosis is a chronic inflammation, triggered by an autoimmune-response, that 
attacks the myelin sheath of nerve fibres (WHO 2008). When someone with MS is 
undergoing an attack the blood-brain barrier, which is normally inaccessible to the white 
blood cells, has broken down somewhere along the brain, spinal cord and optic nerve 
(demyelation) (Oger 2007). This damage along the nerve path results in the inability of the 
affected fibres to conduct impulses—nerve connections are interrupted or lost and symptoms 
such as pain and loss of function appear (MacLean 2010). Myelin can be regenerated in glial 
cells (remyelination) but because of scar tissue (lesions or plaque) function may be 
compromised—especially if the axons themselves are damaged (Ørn 2011). 
 
The causes of MS are unknown but epidemiological studies have given some clues as to why 
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MS occurs. Among these are genetic, environmental and geographical factors as well as the 
possibility of Vitamin D deficiency and a viral infection in childhood (Epstein-Bar virus) that 
triggers the spread of the disease years later in a genetically predisposed person (MacLean 
2010). 
 
3.1.2 Prevalence 
 
On a global scale, the median estimate prevalence of MS is 30 per 100 000 (with a range of 5 
to 80) where Europe has the greatest prevalence (WHO 2008). In countries like Norway the 
prevalence is higher at between 70 to 160 per 100 000 (Ørn 2011). Norway is one of the 
countries in the world with the most MS sufferers in relation to the population (MS Forbundet 
2008). The continent of Africa has the lowest prevalence. Kira (2007) says that the prevalence 
of MS differs widely depending on which part of the world one finds oneself: caucasian 
prevalence is about 40 per 100 000, in East and South Asians it is about 10 while in Africans 
it is even fewer “Such big differences seems to suggest that different genetic backgrounds 
among races strongly affect MS susceptibility”. 
 
 
3.1.3 Diagnosis and prognosis 
 
Unlike many other diseases MS is not easy to diagnose. There is no straightforward specific 
positive or negative diagnostic test for MS, and none of the tests available are 100% 
conclusive (WHO 2008). 
 
Guidelines developed by an international panel (the McDonald criteria) 
on MS extend the previous Poser and Schumacher diagnostic criteria and 
have included welcome simplification in the outcome of diagnostic 
evaluation at any time into the categories MS, possible MS, and not MS  
(Lee and Palace 2007). 
 
But neurologists follow the “McDonald criteria” as a support; diagnosis is still heavily based 
on the skills of the doctor in taking and interpreting the patient’s medical history, neurological 
examination and supporting paraclinical tests and MRI (MacLean 2010). Once this is done, 
after observing symptoms and if all other possibilities are ruled out, the neurologist will 
diagnose MS (WHO 2008). 
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Even though these diagnostic criteria have been developed in order to balance the precision of 
diagnosis, the rates of MS misdiagnosis are as high as 10%. The risk of this is patients not 
receiving disease-modifying agents and missing out on effective therapies early on for MS or 
for one of the many mimics MS has such as Balo, Schilder and Marburg disease all of which 
are considered MS borderline diseases (Lee and Palace 2007). 
 
The course of the disease is variable and the number of attacks and the rate of progression 
varies from patient to patient. Of the three main types, Relapsing-remitting (symptoms appear 
then resolve) is the most common, followed by Primary progressive and thirdly Secondary 
progressive where more than 65% of patients with Relapsing-remitting enter into Secondary 
progressive within 15 years of diagnosis (See table 3.1). Some researchers and text books 
mention a fourth type Progressive relapsing for those people who have relapses as well as 
progression from the start but this is often placed under the Primary progressive type and seen 
as a rare but often aggressive type of MS (MacLean 2008). 
 
Table 3.1: Types of MS (after Ørn) 
 Primary Progressive Relapsing-remitting 
(RRMS) 
Secondary Progressive 
% of diagnosed 10-20% 80-90%% 40-60% 
Description Even progression of 
symptoms from debut 
with often long periods 
of stability 
Acute debut of 
symptoms or attack 
(relapse) which go 
completely or partially 
away (remission) 
Chronic progressive 
phase where patients 
with RRMS enter 
within 15 years. 
Neurological symptoms 
such as paralysis which 
doesn't get better 
(Ørn 2011)    
 
 
 
3.1.4 Symptoms 
 
Common symptoms include: fatigue, spasms, pain, tremor, sensory symptoms (pins and 
needles, numbness or tingling), dysarthria, visual disturbances, cognitive problems (recall, 
problem solving, planning, concentration and word finding), ataxia, mood disturbances, 
sexual dysfunction, weakness and of course, bladder and bowel dysfunction (McLean 2010, 
15 
 
adapted from McDonald and Compston 2006). There is no cure and treatment is solely to 
relieve symptoms and modify the course of the disease. 
 
 
 
3.2 The Bladder 
 
 
3.2.1 Pathophysiology of the bladder 
 
Demyelation can affect any part of the CNS which can result in reduced function anywhere in 
the body. Even with an MRI it isn't possible to determine which particular symptom is related 
to a particular area of demyelation (ibid. 2010). When the bladder is involved it is usually 
because the disease involves the spinal cord (Haslam 2005). 
 
A healthy bladder has two roles: a) to store urine and b) to empty urine. The bladder is a 
hollow organ made up of muscle known as the detrusor. The detrusor muscle relaxes to allow 
the bladder to fill and contracts to empty when voiding. The internal sphincter is a ring of 
muscle holding the neck of the bladder in place. It is controlled by the autonomic nervous 
system. The external sphincter is controlled by the somatic nervous system and is like a tap 
holding urine in the bladder until a person is ready to void. The bladder sits on the pelvic 
floor, these muscles also need to relax to allow for the free flow of urine. If there is 
demyelination or scarring in any part of the sacral spinal cord or brain stem problems with 
bladder control and micruination can occur (Rantell 2009). 
 
Normal voiding “involves reflex detrusor contraction synchronised with voluntary sphincter 
relaxation to achieve complete bladder emptying” (Brady and Fowler 2007) and an intact 
CNS is needed to achieve this (Haslam 2005). Bladder problems occur because of the 
“…incorrect or incomplete conduction of nerve impulses during the storage or voiding phase” 
(Rantell 2009). 
 
Lesions or plaque at different points of the cerebral cortex, brainstem and sacral spinal cord 
have different effects on voiding function. Lesions in the cerebral cortex can lead to detrusor 
hyperreflexia and overactive bladder symptoms of urgency, frequency and urge incontinence. 
Lesions in the pons or sacral spinal cord can lead to hyporeflexia and problems with emptying 
the bladder. Then there are lesions above the sacral spinal cord which can lead an 
uncoordinated contraction to the detrusor muscle and relaxation of the external sphincter 
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muscles causing both incontinence and incomplete bladder emptying. But this may not be 
what's most important. Many MS patients have multiple lesions along multiple sites in their 
CNS and it isn't always possible to determine which lesion is responsible for bladder 
dysfunction (Woodward 2004). 
 
 
3.2.2 Quality of life and bladder dysfunction 
 
Frohman (2007) estimates that at least 96% of MS patients will experience lower urinary tract 
abnormalities after 10 years of disease activity. Fowler et al. (2009) emphasised that the 
severity of these problems often have much to do with the level of the patient’s disability. 
Fowler also says that “several studies have shown that urinary incontinence is considered to 
be one of the worst aspects of the disease” and the symptoms of urgency and frequency and 
especially the uncertainty of incontinence can have a profound effect on a patient’s lifestyle 
and social life. Griffith (2002) stated that many patients are unaware of the treatments and 
management options that are actually available to them and thus suffer the embarrassment and 
restrictions that can come with bladder problems. Many even give up employment earlier than 
necessary because of the negative effect these problems can have on their working life.  
 
People with urinary problems will tolerate symptoms up to a point but only when 
they feel that they are deteriorating will they seek help 
(Brittain et al, 2001, cited by Griffith 2002) 
 
It is here that Woodward (2004) talks about the importance of the nurse’s role in being aware 
of the treatments available and advising patients of their options. It is here nurses can have a 
significant impact in training MS patients to manage their symptoms and regain some control 
over their quality of life “…which has been shown to collapse early in the disease before 
patients become severely disabled” . 
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3.2.3 Symptoms of bladder dysfunction 
 
There are three main groups of bladder problems in MS: Storage dysfunction, emptying 
dysfunction and combined dysfunction (Rantell 2009). 
 
Storage dysfunction is often referred to as an overactive bladder. It is the bladder's inability to 
store sufficient urine as to build up to a normal void at the appropriate time and appropriate 
place (ibid. 2009). The most common bladder problem with MS patients is detrusor over-
activity. A patient may feel the urge to void even if the bladder volume is low because the 
detrusor muscles contract involuntarily. Over-activity can lead to urge incontinence when 
these spasms are associated with leakage (DasGupta and Fowler 2003). 
 
Emptying or voiding dysfunction occurs when the bladder attempts to empty unsuccessfully 
because a) the urethral sphincter fails to relax in order to empty the contents of the bladder,  b) 
the detrusor muscles fail to contract or c) when the external urethral sphincter contracts 
involuntarily at the same time the detrusor contracts (Rantell 2009).  
 
 
Table 3.2 Most common problems 
Symptoms                   Description 
Urgency sudden compelling desire to pass urine, which is difficult to defer 
Urge Incontinence involuntary leakage accompanied by, or immediately preceded by, urgency 
Increased Frequency voiding too often 
Nocturia waking 1 or more times at night to void 
Nocturnal Enuresis loss of urine during sleep 
Intermittency urine flow that stops and starts on 1 or more occasions during micturition 
Hesitancy difficulty in initiating micturition, resulting in delay in the onset of voiding 
after the individual is ready to pass urine 
Source: Haslam 2005 
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3.2.4 Management of bladder dysfunction 
 
Management of the bladder is symptomatic and varies accordingly with each patient. From a 
neurologists point of view the focus is mainly on medications and procedures which can assist 
in reducing the symptoms. From a nursing perspective there are many techniques and tricks a 
nurse can train and advise an MS patient to do. MacLean (2010) says “The MS specialist 
nurse plays a pivotal role in initiating, monitoring and titrating treatments…” and is often the 
first contact for MS patients. 
 
Griffith (2002) discusses the importance of good quality assessment before solution 
suggestions are made. Table 3.3 provides an overview of the key areas of continence 
assessment that should “establish the degree and type of continence problem”. Each MS 
patient with bladder problems should be seen and assessed by a trained health care 
professional who knows and understands how MS affects the bladder (Fowler et al, 2009) 
 
Table 3.3 
Factors considered during continence assessment 
Characteristics of the problem—including nature and duration of symptoms 
How the problem is currently managed 
Past medical, surgical and obstetric history (including drug) 
Bowel habits 
Nutritional and fluid intake 
Functional and cognitive abilities 
Perceptions and expectations 
Effect on quality of life 
Social and environmental factors 
 
 
General Measures 
 
MS patients have a tendency to reduce their fluid intake when they develop bladder problems 
but patients should be encouraged to drink between 1-2 litres a day. The amount should be 
individualized and balanced up against a voiding diary. Dehydration can cause constipation 
creating another problem for the patient (Fowler et al, 2009). Caffeine should be significantly 
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reduced or cut out (Haslam 2005). An MS nurse can assist patients in setting up a diuretic 
chart where patients can record what they consume and void daily to balance out their fluids. 
 
Bladder retraining involves the patient voluntarily suppressing urinary urge and extending the 
intervals between voiding. Even though this is generally a method more appropriate for 
patients who are self-ambulant and cognitively aware, patients should initially be supervised 
by an MS nurse, continence advisor or physiotherapist (Woodward 2004). 
 
Pelvic floor exercises are a therapeutic intervention usually used to treat stress incontinence 
but in MS they can help by strengthening the pelvic floor muscle and “…enhancing the 
inhibitory effect of the floor contraction on the detrusor” (Fowler et al, 2009). The limitation 
is that this form of treatment is mainly for patients with mild MS 
 
Management of impaired voiding 
 
Introduced in 1972, Clean Intermittent Self Catheterisation (CISC) is a safe and effective way 
for patients to empty their bladder. Draining the residual urine reduces the symptoms of 
frequency and urgency and urinary tract infections (UTIs) as these types of infections are 
common among patients with incomplete emptying (Brady and Fowler 2007). CISC is a clean 
procedure and depending on the post void residual volume can be used between one to five 
times per day if necessary. In order to achieve good compliance the procedure should be 
taught by nurses who have experience in teaching the technique (Fowler et al 2009). “Most 
patients, including those with reduced mobility and dexterity, can be taught to self-
catheterise” (Haslam 2005). Despite the fact that it isn’t a sterile procedure evidence shows 
that CISC doesn’t increase the incidence of UTIs (Griffith 2002). 
 
When the combination of medication and CISCs are no longer effective, particularly because 
of increasing disability, an indwelling catheter should be considered (DasGupta and Fowler 
2003). It is preferable that it be done suprapubically rather than urethrally partly because of 
the risk of progressive urethral damage seen in MS patients but also because of the restrictions 
in having sexual relationships (Fowler et al 2009). 
  
According to Fowler et al (2009), there is evidence that suggests that suprapubic vibration via 
a hand held vibrating contraption can help initiate detrusor contractions and improve bladder 
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emptying but that it has a limited effect. Bladder stimulation using Crede’s manoeuvre 
involves compression using the hands has been practised for many years by patients 
(Woodward 2004) but not all experts believe in its effectiveness or know what sort of long 
term effects it has on MS patients (Fowler et al 2009).  
 
Management of overactive bladder 
Medications patients can take for detrusor over-activity include anticholinegics (such as 
oxybutynin and tolterodine) which are inhibitors for nerve impulses, and tricyclic 
antidepressants which work on the kidneys and increase reabsorption at the collecting tubule 
and reduce urine formation. Antichololinergics have some uncomfortable side effects; the 
most common is dry mouth, then drowsiness, constipation and blurred vision but slow release 
medications are available that considerably reduce the incidence of dry mouth (DasGupta and 
Fowler 2003). 
 
Intravesical agents are rarely used because they require frequent catheterization but they work 
by being inserted directly into the bladder.   
 
Botulinium toxin A appears to be a highly effective method for treating over-active detrusor 
problems. Studies show that it is successful in reducing frequency, urgency and some 
incontinence but it isn’t clear exactly how it works on the bladder (Halsam 2005). 
 
Desmopressin spray or DDAVP taken at night can effectively resolve the problem of nocturia 
and can reduce the output of urine for up to eight hours. Some patients use it during the day 
for undisturbed meetings or work commitments but DDAVP should be taken with caution and 
only once within a 24 hour period because of the danger of fluid overload (Haslam 2005). 
 
According to Fowler et al (2009), there is evidence that cannabinodis based medication is 
somewhat effective in alleviating lower urinary tract symptoms. In a recent article in 
Norway’s Aftenposten this February, Sweden will be introducing cannabis mouth spray as a 
medicine for pain and stiffness problems in patients with MS (Svarstad 2012).  
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Diuretics can be of assistance but there is no evidence for the effect directly on MS patients. It 
can help patients who have problems with nocturia polyuria (one third of daily urine output 
happening at night) to take a diuretic in the afternoon to reduce night-time frequency (Fowler 
et al 2009). 
 
Surgical 
Urinary diversion procedures could help some patients with MS but according to Fowler et al. 
(2009) the need for surgical intervention for intractable urge incontinence has reduced since 
the introduction of botulinum toxin treatment. It is often in situations where patients that have 
become intolerant to long term catheters with frequent blockages, UTIs, sepsis and leakage 
that surgery might be necessary. In women such a diversion can be done suprapubic or 
vaginal, while in men it can be suprapubic or perineal. There is also the option of completely 
bypassing the bladder where an ileal conduit urinary diversion is possible (Brady and Fowler 
2007).  
 
 
3.3 The Bowels 
 
 
3.3.1 Pathophysiology of the bowels 
 
Bowel control is a complex process involving the coordination of many different muscles and 
nerves. The gastrointestinal tract is a continuous organ system designed to help the body 
absorb the nutrients and fluids it needs and then to expel waste (Adelson 2011). The enteric 
nervous system (mediates the contractions of the muscular layer) directly controls the 
gastrointestinal system and is composed of both the outer myentric plexus (a network of nerve 
fibres located within the layer of muscular tissue that lines the oesophagus, stomach, and 
intestines) and an inner submucosal plexus (regulates local secretions, blood flow, and 
absorption)  (DasGupta 2003). 
 
Unlike the bladder, which has been researched in terms of the level of neurological deficit 
involved, less is known about bowel disorders in MS and how demyelation affects the 
processes involved (DasGupta and Fowler 2003). Adelson (2011) puts it interestingly when 
she says  
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The human gut is said to be a second brain because of the way it's plugged 
into the nervous system. If that's true, the gut in a body with MS isn't very 
bright (ibid. 2011). 
 
The digestive system works by pushing food through the intestines. Peristalsis squeezes the 
food through the different sections of the intestine. These different sections are separated by 
sphincters, which act as valves. The colon begins in the last section of the small intestine and 
curves all the way around to the rectum. This muscular tube is made up of the ascending 
colon, the transverse colon and the descending colon which ends at the rectum and the anus. 
The colon's most important job is to store, process and get rid of waste. The colon also 
absorbs some nutrients and water. All this works because there are the trillions of bacteria 
resident in the colon which collectively make up the gut flora. The rectum can store waste but 
most of the time it is empty. Waste is expelled through the anus (Emmanuel 2010). 
 
In MS damage to nerve cells in the cervical and thoracic portions of the spine can result in 
upper motor neuron bowel. Waste moves through the bowel slower than normal and allows 
the intestine to draw out more water. On top of this, MS can “make the external anal sphincter 
stiff and spastic” which prevents it from relaxing when a patient needs to defecate (Adelson 
2011). 
 
 
3.3.2 Quality of life and bowel dysfunction 
 
“Lack of bowel control can have devastating effects on the individual, lowering their self-
esteem and confidence”. Some of these effects may include the individual restricting what 
they do with their lives and isolating themselves (Brady 2007). Bowel problems are among 
the most distressing problems of MS and affect the ability to socially integrate and live 
independently (Emmanuel 2010). Norton and Chelvanayagam (2010) conducted a survey 
asking MS patients to describe their complaints. The following illustrate their situation: 
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1) [I] try to go to the toilet early in the day so that I can go out and be 
fairly safe that I won't have any disasters. I do not stray far from a 
toilet, so although I love the country I rarely go there to walk as I used 
to. 
 
2)  Bowel problems are immense – little to no control, problem with 
mobility when needing to rush. Urinary problems totally controlled by ISC 
+ Sheath + Bag. If only there was something similar for bowel problems. 
 
 
3.3.3 Symptoms of bowel dysfunction 
 
The most common problems in bowel dysfunction are constipation, impaction and 
incontinence but of these three, constipation is the one causing the most discomfort (Froham 
2007).  Severe constipation is sometimes the first presenting symptom of MS and has been 
reported as predating diagnosis in many cases (Norton and Chelvanayagam 2010). 
 
Constipation: There are two general categories of constipation: decreased colonic transit time 
and outlet obstruction (Brady 2007). The abdominal muscles are supplied by T6-T12 spinal 
cord segments and if there is demyelation in these levels problems can arise with a reduction 
in the neuro-gastrointestinal signalling (Froham 2007). A sluggish gut can result in slow 
transit of faeces while in outlet obstruction evacuating the rectum could be because of a 
failure to relax the pelvic floor or anus during defecation (Brady 2007). 
 
Constipation is a common cause of painful defecation and can cause both physical and social 
difficulties because of the discomfort, abdominal distension and pain associated with it 
(DasGupta and Fowler 2003). Despite the fact that demyelation in the spine can be one of the 
causes of constipation and bowel dysfunction there are factors other than MS itself that that 
could be causing the problem. The side effects of drugs (opiate-based painkillers, 
antidepressants) depression, immobility, weak abdominal muscles (due to immobility, for 
example), dehydration, diet or even other medical problems contribute largely to the problems 
with an MS bowel (Brady 2007).  
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Prolonged constipation can lead to other complications such as anal fissures, haemorrhoids 
and even rectal prolapse as a result of straining and this can result in a worsening of quality of 
life (DasGupta and Fowler 2003). 
 
Impaction: is a solid, large lump of dry, hard stool that remains stuck in the rectum. It is often 
the result of long time constipation and can cause discomfort, bleeding and overflow 
incontinence when liquid stool bypasses the hard mass (Brady 2007). Chronic straining in 
situations like this can also cause intussusception (intestinal invagination) (Froham 2007). 
 
Faecal Incontinence: Is probably the most embarrassing of the problems. Losing control, 
involuntary excretion and leaking is not socially acceptable and can be associated with shame 
and humiliation (DasGupta and Fowler 2003). Causes for faecal incontinence can involve 
damage to the anal sphincters and pelvic floor incompetence, diarrhoea (sometimes due to 
medications or infections), rectal prolapse (due to constipation and or straining) or even 
sensory defects (impaired sensation of rectal fullness) (Brady 2007). 
 
 
3.3.4 Management of bowel dysfunction 
 
There is an urgent need for further research on the management of bowel 
problems in MS. In common with the epidemiological research treatments for 
bowel dysfunction have received much less attention than bladder dysfunction  
(Hay-Smith 2007) 
 
Assessment 
Like with bladder problems bowel dysfunction is largely symptomatic and varies from patient 
to patient. It is important to identify problems that indicate gut pathology and figure out what 
bowel function was like prior to MS symptoms (Emmanuel 2010). See table 3.4 for an 
overview of assessment criteria. As Brady suggests bowel dysfunction and management that 
follows can have a huge impact on the individual both physical and psychologically and 
patients need a good deal of support combined with information and explanation of their 
problem (Brady 2007).  
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Table 3.4 
Symptoms to note in Assessment of bowel dysfunction 
Frequency of urge to void rectum 
Bowel opening frequency 
Time spent per bowel episode 
Steps needed for emptying (laxatives, digital stimulation, carer help etc.) 
Episodes of urge faecal incontinence 
Episodes of faecal soiling 
Meal frequency and content 
Emmanuel 2010 
 
DasGupta and Fowler (2003) discusses how bowel dysfunction in MS patients may be 
multifactorial; due to the MS or due to other factors mentioned earlier but as Emmanuel 
(2010) puts it even if the pathophysiology of bowel symptoms varies between patient groups 
treatment is often the same. He goes on further to say 
 
The evidence base for managing neurogenic bowel dysfunction is limited, and in 
general a step-wise approach of gradually escalating degree of invasiveness has 
been advocated.  
 
Prior knowledge of bowel frequency is just as important. A patient who previously only had 
bowel openings two or three times a week cannot be expected to follow a daily bowel regime 
after diagnosis (ibid. 2010). Solutions need to be creative and imaginative and adapted to the 
patient’s needs, abilities, lifestyle and amount of help received (Brady 2007) and it is often 
here that nurses can be a great resource. 
 
Constipation 
 
General Measures 
 
Enough fluid intake is probably one of the most important things a patient with MS can do for 
their bowels. Most patients with bowel symptoms have bladder problems too and reduce the 
amount of fluid they consume to avoid bladder urgency. Maintaining a high fluid intake may 
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affect bladder dysfunction requiring the patient to perform self-catheterisation more often 
however the benefits outweigh the negative aspects of dehydration and often painful 
constipation (DasGupta and Fowler 2003). High fibre intake with daily portions of fruit and 
vegetables as well as insoluble fibres might be useful for patients with a lower motor neurone 
type bowel as it helps improve the stool consistency (Emmanuel 2010). However it has been 
found that dietary fibre was actually ineffective in patients with chronic constipation and 
might actually induce symptoms of bloating and abdominal distension (DasGupta and Fowler 
2003). 
 
Bowel contractions are often brought on after a meal, especially in the morning after waking 
up and patients should try to schedule their bowel movements at around this time (Emmanuel 
2010). This process is known as the gastrocolic reflex but is often blunted in MS patients. 
However patients should be encourage to find out which part of the day their post-meal urge 
to defecate is strongest (Frohman 2007). 
 
Mobility or lack of it seems to be one of the contributing factors of constipation. Activity 
stimulates colon peristalsis and it’s important to encourage patients with constipation to do 
something active to the best of their ability (Kristoffersen et al. 2005: bind 2, pg. 210).  
 
Medication 
In a survey of MS patients and how they manage their bowels, Norton and Chelvanayagam 
(2010) say that medication was found to be the most effective intervention for both 
constipation and faecal incontinence. Bulking agents such as psyllium and methylcellulose are 
often used in situations where diet change fails. Peristalsis is stimulated by increasing the size 
of the stool as this puts more pressure on the bowel walls and increase the neural signal which 
in turn helps motility (Adelson 2011). However, Brady (2007) warns that bulking agents can 
be counter-productive if peristalsis is somehow hindered and can contribute to impaction 
especially in immobile patients. Extra hydration is also important when using such substances 
(see General Measures for consequences). 
 
DasGupta and Fowler (2003) discuss osmotic laxatives (lactulose and macrogols) as the safer 
and non-habit forming laxative. These help retain fluid in the bowel making faeces and softer 
and more mobile through the colon. Stimulate laxatives (senna, bisacodyl) increase intestinal 
motility and are less likely to produce a liquid stool. 
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Other Measures 
 
MS patients tend to have their own creative and individual tricks to solving their bowel 
problems with varying degrees of success (Norton and Chelvanayagam 2010). Abdominal 
massage can help move the stool towards the rectum. The Valsalva manoeuvre (breathing hard 
against a closed glottis) can help but should be avoided by patients who in addition have 
cardiorespiratory problems.  
 
Digital stimulation: circular motion of the finger in the anal canal can encourage a reflex 
contraction of the colon and is also a good way of checking if there is any stool in the rectum. 
Manual extraction is different and doesn’t involve a reflex contraction, rather physical 
removal of the stool. Patients should receive training in this method  
 
Suppositories and enemas are effective by causing a reflex contraction of the rectum but there 
is little effect if the stool is stuck further up the colon and the rectum is empty (Emmanuel 
2010). 
 
Table 3.5 Types of drugs used for constipation 
Class Examples 
Bulking agents Natural bran, Sterculia, Ispaghula husk 
Stool softeners Castor oil, Sodium dioctyl sulfosuccinate 
Stimulant laxative Senna, Bisacodyl 
Osmotic laxative Lactulose, macrogols 
Rectal stimulant Suppository, Enema 
Source: DasGupta and Fowler 2003 
 
Electrical stimulation therapy involves sacral nerve stimulation where one or more electrodes 
are implanted surgically onto the sacral roots and has been effectively used on patients with 
both constipation and incontinence. This is a major surgical procedure that has usually been 
done for bladder management but has shown to improve bowel function (ibid 2010). 
 
Surgical stoma is often regarded as the last step and DasGupta and Fowler (2003) suggest that 
it is only indicated in rare circumstances when all other management forms have failed. As 
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Emmanuel (2010) writes time spent with bowel care is reduced but the gut is still sluggish and 
requires laxatives to move the stool. 
 
Faecal incontinence 
Faecal incontinence is relatively uncommon in MS and can usually be associated with 
untreated constipation. A number of other factors contributing to incontinence could include 
“…reduced sensation of rectal filling, poor voluntary contraction of the anal sphincter and 
pelvic floor musculature, and reduced rectal compliance” (Frohman 2007). 
 
As with urine incontinence, irritants such as caffeine and alcohol should be avoided. Diapers 
and pads could be of assistance as well as timed scheduling of elimination with suppository 
treatment or enemas (ibid 2007). 
 
Brady (2007) suggests that patients experiencing faecal incontinence could benefit from low-
dose constipating medication. Medications such as Loperamide or Codeine phosphate should 
be taken prior to eating and could reduce faecal incontinence and improve stool consistency. 
Combining these medications with a planned evacuation regime with suppositories or enemas 
could improve control over the bowels but also risk the side effects of constipation. 
 
Brady (2007) goes on to report that other than pads there are very few products available for 
faecal leakage. Anal plugs can be uncomfortable and give a constant feeling of rectal fullness. 
Surgery is another option; stoma, anal sphincter repair, post anal repair…but this is (as 
mentioned above) only done in situations where all other possibilities have been exhausted.  
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3.4 Nursing theory: Travelbee 
 
Joyce Travelbee was born in New Orleans in 1926 and worked as a psychiatric nurse and 
developed the Human-to-Human Relationship model presented in her book Interpersonal 
Aspects of Nursing in 1966. The crux of Travelbee’s theory is the establishment and 
development of the nurse-patient relationship (Kristoffersen 2005: chapter 23). 
Travelbee’s nursing theory relates to each person as being an individual and unique. Central 
to this is the idea that suffering and loss are common human experiences. Nursing is defined 
as an interpersonal process where the nurse assists the patient to cope with illness and find 
meaning through self-actualisation in the experiences that arise from suffering and illness. 
Nursing is accomplished through relationships between humans; an initial encounter then the 
development of stages of emerging identities and then development of feelings of empathy 
and sympathy (Parker and Smith 2010: pg. 76). 
Hope helps a suffering person cope and it is the role of the nurse to help the individual 
experience hope in order to handle the stress of illness and suffering. If a person loses hope 
they lose the motivation to change their situation and the belief that the problem can be solved 
(Kristoffersen 2005: pg. 24). In order to ease suffering nurses provide care on an individual 
basis and according to Travelbee this is done in 5 stages: observation, interpretation, decision-
making, action and appraisal. It is possible to achieve each stage without the human-to-human 
relationship but according to Travelbee only the person’s acute medical needs are met while 
the patient’s deeper spiritual needs are neglected. The five stages in the human-to-human 
relationship are: the original encounter, emerging identities, empathy, sympathy and rapport. 
A bond is created between the nurse and patient and through this bond each interaction “… is 
facilitated by the therapeutic use of self, combined with nursing knowledge” (Parker and 
Smith 2010: pg. 76). Through this bond nurses can help people who are suffering look for 
hope in their surroundings, something Travelbee suggests is a part of people’s basic trust in 
the outside world as long as this world remains safe and accommodating and help is available 
when needed (Kristoffersen 2005: pg. 27). 
Parker and Smith (2010) quote Travelbee when they say  
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Hope and motivation are important nursing tasks in caring for an ill 
person in despair. However, the nurse “…cannot give hope to another 
person, she can, however, strive to provide some ways and means for an 
ill person to experience hope” 
(Travelbee, 1971, as quoted in Parker and Smith 2010) 
 
This hope isn’t a blind hope about a cure for an illness that has no cure, rather one where the 
patient comes to term with the illness and suffering and makes the most of the situation As 
Kristoffersen (2005: pg. 27) suggests, hopes and wants are not the same. Wants are often 
unrealistic and unachievable: like winning the lottery. According to Travelbee, this is not 
hope. In order to hope we need to evaluate whether that we hope for is achievable (ibid. 2005: 
g 27). 
It is through communication that nurses get to know a patient and according to Travelbee 
communication is one of the most important tools a nurse has to establish a human-to-human 
contact with a patient (ibid. 2005: pg. 31). The goal of Travelbee’s stages in the progression 
of the human-to-human relationship is ultimately the final rapport between patient and nurse. 
It is important to note that rapport isn’t always established but it is  
Through the establishment of rapport, the nurse is able to foster and 
meaningful relationship with the ill person during multiple points of contact in 
the care setting. 
(Parker and Smith 2010: pg. 77) 
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4.0 Discussion 
It is in this section that I would like to take the opportunity to discuss what nurses can do to 
ease and limit the discomfort of waste elimination in patients with MS. The literature study I 
have done shows that there is a lack of neurological knowledge about the disease. It shows the 
deficiency in research around, in particular, bowel dysfunction but behind all the medicine, 
behind all the terminology it also reveals the underlying importance of the role nurses play 
when it comes to patients who have these problems. 
 
The neurological aspect 
Fowler et al (2009) introduce their article by saying there are thought to be 85 000 people in 
the UK living with MS, that it is the most common progressive neurological disease affecting 
young people. A quick search on Google and one discovers that there are over 62 million 
people living in the UK. The math would be 0.0013%. Another quick search on Google and 
one discovers that in just one year in 2008, 309 500 were diagnosed with cancer. That’s 
0.005%. Also not a very large number but this was in one year, not total. These numbers 
aren't based on any in depth research—just randomly plucked out from the World Wide 
Web....but it paints a picture, hints at a clue. It's no wonder, really, when one looks at the 
numbers, that problems relating to the bladder but especially bowel in MS are under-
researched. 
 
DasGupta and Fowler (2003) mention it as often considered to be amongst the most 
distressing problems “[...] these problems have often been neglected in the past, partly 
because of the perceived private nature of the problems”. And yet, there are 2 to 3 times more 
patients with MS admitted into hospital for impaction, megacolon, constipation and volvulus 
as the non-neurological population. “Despite the high prevalence, there has been little 
attention on bowel dysfunction” (Norton and Chelvanayagam 2010). 
 
However, as suggested in the theory, bladder and bowel problems are largely symptomatic 
(Section 3.2.4 and 3.3.4). Despite the evidence of this being the case MS patients shouldn’t be 
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having the problems they are having. Is it the private nature of the dysfunction, as DasGupta 
and Fowler suggest, that is the problem?  
 
Woodward (2004) discusses that management of continence symptoms usually falls within 
the domain of nursing and that good nurses are up to date with current treatments available for 
patients. She writes about bladder dysfunction in her article but this viable for bowel 
dysfunction too. Nurses play an important role here and not just in institutions where severely 
disabled MS patients can end up. The role of the nurse doesn’t have to be that of a purely 
physical carer but also one of advisor, listener and trainer. MacLean (2010), who talks about 
the role of the nurse in management of the disease as a specialist who provides support and 
information, mentions how many MS patients come up with their own tricks and techniques 
to combat the various irritations in their daily bladder and bowel regime. This sort of 
information is gold for nurses. With so little research done, especially on the bowels, 
experiences from other patients are paramount to expanding the nurse’s knowledge. 
 
Human-to-human relationships 
It isn’t just experience and knowledge that counts. If one takes into consideration what 
Travelbee says about human-to-human relationships a lot of what patients go through 
shouldn’t just be looked at from a medical perspective. Nurses need to look at the patient as a 
whole—medical as well as the deeper spiritual needs. By doing this nurses can establish a 
relationship with the patient and then through communication and a “…logical approach 
consistent with nursing standards and clinical practice guidelines…” figure out what the 
problem or need is (Parker and Smith 2010: pg. 77). After these needs are established only 
then can a solution or treatment be found.  
 
Griffith (2002) reports that some patients feel their bladder and bowel problems are ignored 
by medical staff once they've been diagnosed with MS. Healthcare professionals need to stay 
alert and be wary of the problems patients face. Just because it is a symptomatic disease does 
not mean that management should cease when diagnosis is given. On the contrary, because it 
33 
 
is a symptomatic disease, this should encourage nurses to use all the tricks they have in their 
arsenal to help ease the discomforts patients have. 
 
Rantell (2009) lists it as the third most embarrassing symptom complex in a survey done by 
the MS Society in Austria. This isn’t surprising when one looks at the other elements of life 
that are affected by bladder and bowel dysfunction. It isn’t without reason that sexual 
dysfunction is often discussed together with the bladder and bowel. Just the thought of a 
catheter or colostomy bag can send most people off the deep end. Consider the impact such 
things can have on a relationship. Especially taking into account the age at which MS has 
tendency to debut.  
 
This doesn’t mean the end of a relationship or even the end of a sexual relationship between 
partners. Haslam (2005) talks about the preference of a suprapubic catheter over urethral. Not 
only does this make changing and hygiene easier but it is often more comfortable especially 
for women and wheelchair users. There is also less irritation on the urethral wall and makes it 
easier for partners to engage in sexual activity. 
 
This sort of information needs to be provided for patients early on in the diagnosis, and it is 
here that the importance of a multidisciplinary team should be made available for the patient 
with the possible primary contact being an MS nurse. Griffith (2002) suggests that without 
specialist advice, patients could develop more serious problems, both physical and 
behavioural, in the long term. This can relate to several other problems faced by MS patients 
with bladder and bowel dysfunction. 
 
Establishment of hope 
It isn’t just the physical problems that need to be addressed. The impact information like this 
has on the patient’s psyche needs to be addressed too. One of Travelbee’s main concerns 
when it comes to the human-to-human relationship between nurses and patients is the 
establishment of hope. Not blind hope where a cure for MS is on the horizon and all the 
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patient’s cares are over but realistic hope where a patient can come to terms with the illness 
and make the most of the situation. A nurse can help the patient discover that bladder and 
bowel problems are not the end of the relationship with a partner but an obstacle that can be 
met and circumvented with a little nursing knowledge and creativity. 
 
Adler (2011) suggests that we tend to take our bodies for granted as we eat “lousy food” and 
engage in irregular eating habits, and it isn’t until something goes wrong that we realise how 
remarkably our system works. This doesn’t mean that MS patients are to blame for their 
bowel problems but with the right diet much can be done to ease a good portion of the 
discomfort a sluggish MS bowel can cause. Patients don’t need to be alone out there, suffering 
from symptoms that can be helped. In their training nurses learn the importance of diets and 
what foods work in what ways. Their knowledge of the way the bowels function can be 
invaluable for MS patients with bowel dysfunction. On top of this, nurses have a network of 
people they can work together with to discuss and help find solutions for each patient. 
 
The unique patients 
“It may be observed that no two cases of any disease are alike, but this is particularly so for 
multiple sclerosis” (McDonnell 2007). The issue here is what can be done to help MS patients 
with their problems. What can individually be done, for each patient, to ease the discomforts 
bladder and bowel dysfunction cause? It is here that Travelbee’s theory comes into light 
again: looking at the patient individually, as a whole. The problem one patient has with 
constipation doesn’t necessarily stem from the same reasons the next patient does. This is 
where looking at the patient through the five stages of observation—interpretation, decision 
making, action and appraisal—as a whole, as an individual is so important. What sort of 
problems does this patient have with their bladder? Here the nurse can use Tables 3.2 and 3.3 
in the theory section to help the patient establish what sort of bladder problem they have 
(urgency, hesitancy etc.) and what factors need to be considered during continence 
assessment. It is here that Travelbee’s theory becomes more than an idea; it is here it can be 
put into practice. Travelbee may refer to each patient as an individual and unique but central 
to her theory is that suffering and loss are common human experiences. This could be 
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interpreted in such a way that even though each patient should be treated as an individual the 
treatment is often similar and something the nurse has experienced with other patients before. 
 
The individualistic forms that MS has a tendency to take on (as quoted in section 1.3) often 
create a challenge or conflict in nursing ideals. One symptom is treated a certain way only for 
it to clash or create problems for another. Medication that an MS patient takes for pain often 
causes issues for the bowels: opiates can contribute to constipation.  Another is where MS 
patients reduce fluid intake to avoid urgency which can again contribute to constipation. Yet 
over-hydration can result in cardiorespiratory problems for patients who in addition to MS 
have heart problems. Mobility is one of the best ways to get the bowels moving but how does 
one get a wheelchair-bound patient up and about? It isn’t impossible but definitely a 
challenge. It is this clash in nursing that requires nurses to realise Travelbee’s approach to 
each patient as an individual. 
 
MS is not an easy illness to diagnose. Lee and Palace (2007) discuss that neurologists have 
guidelines to follow, a criteria to interpret the patients history and symptoms but what of the 
patient’s general practitioner? How easy is it for a family doctor to refer a patient to a 
specialist when the diagnosis is so difficult, when there are so many mimics, when the 
symptoms a patient has can point to number of diseases? The authors go on to mention how 
even with these guidelines the rate of misdiagnosis is as high as 10%. At the risk of repeating 
myself, is the solution again as Travelbee suggests, an individual analysis? In this day and age 
of rush, rush, rush where one is limited to a ten minute visit with one’s doctor it is easy to 
assume the symptoms relate to something else. And since MS is a symptomatic disease unless 
the patient comes to a specialist it could take a long time before actual diagnosis is made. 
 
Until research comes up with a way to rid the body of its demyelation problem, a way to get 
rid of lesions caused by demyelation, MS will continue to be a symptomatic disease. These 
symptoms will continue to cause patients discomfort. The challenge for nurses and other 
health personnel here is to work closely with each patient in order to find solutions and 
treatments that are directly suited them. This goes for all symptoms, not just bowel and 
bladder dysfunction. 
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Summary and conclusion 
The main discovery from this literature study seems to be the importance of viewing and 
treating each patient on an individual basis. In nursing this should go for all patients and not 
just those with MS but no other disease affects the individual in such different ways as does 
MS. In section 3.1.3 the World Health Organisation points out how difficult it is to diagnose 
MS and how it is possible to misdiagnose MS because of the mimics and individual nature of 
the disease. There are guidelines a neurologist can follow but no real cues to pin point MS—
no “…straightforward specific positive or negative diagnostic test…” (WHO 2008).  This is a 
challenge for all health professionals but particularly for nurses. Use Travelbee’s theory 
practically. Treat each patient individually. Listen to the patient and work with the patient to 
come up with the best possible solutions for coping with the discomforts bladder and bowel 
dysfunction cause. 
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